NCT06859840 2026-03-10
LEAF
Zhejiang University
Phase NA Active not recruiting
Clinical Trials
21 trialsNCT06938945 2026-03-10
Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Hepatocellular Carcinoma During Immunotherapy (PRIME-HCC): Protocol for a Randomised Controlled Trial
Peking University
Phase NA Active not recruiting
NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT01918683 2026-01-29
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
Abramson Cancer Center at Penn Medicine
Phase NA Active not recruiting
NCT04573881 2026-01-12
#HOPE4LIVER
HistoSonics, Inc.
Phase NA Active not recruiting
NCT06579833 2025-12-16
Histotripsy (HistoSonics®) for Liver Tumours
The University of Hong Kong
Phase NA Active not recruiting
NCT03896646 2025-11-21
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT02293954 2025-11-14
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer
City of Hope Medical Center
Phase NA Active not recruiting
NCT04785534 2025-10-14
Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05128032 2025-10-08
PEDIR
Massachusetts General Hospital
Phase NA Active not recruiting
NCT05038254 2025-08-12
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06248528 2025-07-16
Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.
Tongji Hospital
Phase NA Active not recruiting
NCT06312826 2025-05-31
Abbreviated MRI Using Gadoxetic Acid Versus Ultrasonography for Surveillance of Early-stage HCC in Patients at High Risk
Asan Medical Center
Phase NA Active not recruiting
NCT04791735 2025-05-28
LapCHC
Assistance Publique - HĂ´pitaux de Paris
Phase NA Active not recruiting
NCT06204159 2025-05-20
Trinav
Abramson Cancer Center at Penn Medicine
Phase NA Active not recruiting
NCT02984566 2025-04-04
TROG1703 LARK
University of Sydney
Phase NA Active not recruiting
NCT05612477 2025-03-17
SOLT
University Health Network, Toronto
Phase NA Active not recruiting
NCT06682377 2024-11-12
SM-OCT-01
Seoul National University Hospital
Phase NA Active not recruiting
NCT04180072 2024-07-05
Atezolizumab Plus Bevacizumab With HCC and HBV Infection
National Health Research Institutes, Taiwan
Phase NA Active not recruiting
NCT05705791 2024-07-05
HOLMBRAVE
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Active not recruiting
NCT05433701 2023-08-18
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
Phase NA Active not recruiting